These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 16700898

  • 1. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G, Shin JM, Howden CW.
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [Abstract] [Full Text] [Related]

  • 2. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM, Cho YM, Sachs G.
    J Am Chem Soc; 2004 Jun 30; 126(25):7800-11. PubMed ID: 15212527
    [Abstract] [Full Text] [Related]

  • 3. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
    Freston JW.
    Am J Gastroenterol; 1997 Apr 30; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
    [Abstract] [Full Text] [Related]

  • 4. Pharmacology of proton pump inhibitors.
    Shin JM, Sachs G.
    Curr Gastroenterol Rep; 2008 Dec 30; 10(6):528-34. PubMed ID: 19006606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM, Homerin M, Domagala F, Ficheux H, Sachs G.
    Biochem Pharmacol; 2006 Mar 14; 71(6):837-49. PubMed ID: 16405921
    [Abstract] [Full Text] [Related]

  • 8. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K, Carlsson E.
    Pharmacol Ther; 2005 Dec 14; 108(3):294-307. PubMed ID: 16000224
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.
    Galmiche JP, Bruley Des Varannes S, Ducrotté P, Sacher-Huvelin S, Vavasseur F, Taccoen A, Fiorentini P, Homerin M.
    Aliment Pharmacol Ther; 2004 Mar 15; 19(6):655-62. PubMed ID: 15023167
    [Abstract] [Full Text] [Related]

  • 14. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G, Shin JM, Vagin O, Lambrecht N, Yakubov I, Munson K.
    J Clin Gastroenterol; 2007 Jul 15; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [Abstract] [Full Text] [Related]

  • 15. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
    Metz DC, Ferron GM, Paul J, Turner MB, Soffer E, Pisegna JR, Bochenek WJ.
    J Clin Pharmacol; 2002 May 15; 42(5):512-9. PubMed ID: 12017345
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AP, Jagtap JR, Bhosale AV.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1181-205. PubMed ID: 17150362
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT.
    Basic Clin Pharmacol Toxicol; 2006 Jan 01; 98(1):4-19. PubMed ID: 16433886
    [Abstract] [Full Text] [Related]

  • 19. Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.
    Nandi J, Das PK, Zinkievich JM, Baltodano JD, Levine RA.
    Clin Exp Pharmacol Physiol; 2009 Feb 01; 36(2):127-34. PubMed ID: 18759857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.